Activity of the Diaminopyrimidine AR-709 against Recently Collected Multidrug-Resistant Isolates of Invasive Streptococcus pneumoniae from North America

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

Broth microdilution was used to determine the MICs of AR-709 and comparator antimicrobial agents for 224 invasive multidrug-resistant isolates of Streptococcus pneumoniae. AR-709 was highly active, with a MIC 50 of 0.25 microg/ml, a MIC 90 of 0.5 microg/ml, and a range of <or=0.008 microg/ml to 1 microg/ml.

Knowledge Graph

Similar Paper

Activity of the Diaminopyrimidine AR-709 against Recently Collected Multidrug-Resistant Isolates of Invasive Streptococcus pneumoniae from North America
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activity of AR-709 against Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2008.0
Antistreptococcal Activity of AR-709 Compared to That of Other Agents
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activity of Iclaprim against Respiratory and Bacteremic Isolates of Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2009.0
Prevalence of Serotype 19A Streptococcus pneumoniae among Isolates from U.S. Children in 2005-2006 and Activity of Faropenem
Antimicrobial Agents and Chemotherapy 2008.0
In V itro Activity of the Aminoglycoside Antibiotic Arbekacin against Acinetobacter baumannii-calcoaceticus Isolated from War-Wounded Patients at Walter Reed Army Medical Center
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types
Antimicrobial Agents and Chemotherapy 2009.0
Comparative Activities of TR-700 (Torezolid) against Staphylococcal Blood Isolates Collected in Spain
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime
Antimicrobial Agents and Chemotherapy 2008.0
Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
Antimicrobial Agents and Chemotherapy 2010.0